Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2019
2019 World Conference on Lung Cancer
Access to all presentations that occur during the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2848
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P1.01 - Advanced NSCLC
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
- Presentations: 1
- Now Available
- Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
-
+
P1.01-133 - Randomized Open-Label Study of Bintrafusp Alfa (M7824) vs Pembrolizumab in Patients with PD-L1 Expressing Advanced 1L NSCLC (Now Available)
09:45 - 09:45 | Presenter: Myung-Ju Ahn
- Abstract
Loading...
-
+
P2.04 - Immuno-oncology
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
- Presentations: 0
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.04-12 - Ph I Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and SBRT to Multiple Sites in Patients with Stage IV NSCLC
10:15 - 10:15 | Presenter: Jyoti D Patel
- Abstract
Loading...
-
+
P2.14 - Targeted Therapy
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
- Presentations: 0
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.14-12 - Tyrosine Kinase Inhibitor Resistance Mechanisms in EGFR T790M-Positive Lung Cancer: The University of Chicago Experience
10:15 - 10:15 | Presenter: Garth William Strohbehn
- Abstract
Loading...
-
+
P2.18 - Treatment of Locoregional Disease - NSCLC
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Locoregional Disease - NSCLC
- Presentations: 1
- Now Available
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.18-01 - A Multicenter, Double-Blind, Randomized, Controlled Study of Bintrafusp Alfa (M7824) in Unresectable Stage III NSCLC (Now Available)
10:15 - 10:15 | Presenter: Everett E. Vokes
- Abstract
Loading...
-
+
MA14 - The Adequate MTarget Is Still the Issue
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Presentations: 1
- Now Available
- Moderators:Diego Signorelli
- Coordinates: 9/09/2019, 15:45 - 17:15, Hilton Head (1978)
-
+
MA14.03 - EGFR M+ Subgroup of Phase 1b Study of Telisotuzumab Vedotin (Teliso-V) Plus Erlotinib in c-Met+ Non-Small Cell Lung Cancer (Now Available)
15:55 - 16:00 | Presenter: D. Ross Camidge
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA12 - Profiling the Multidisciplinary Management of Stage III NSCLC
- Type: Oral Session
- Track: Treatment of Locoregional Disease - NSCLC
- Presentations: 1
- Now Available
- Moderators:Dirk De Ruysscher
- Coordinates: 9/09/2019, 15:45 - 17:15, Seoul (2007)
-
+
OA12.04 - Discussant - OA12.01, OA12.02, OA12.03 (Now Available)
16:15 - 16:25 | Presenter: Everett E. Vokes
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA14 - Update of Phase 3 Trials and the Role of HPD
- Type: Oral Session
- Track: Immuno-oncology
- Presentations: 0
- Moderators:Julie R Brahmer
- Coordinates: 9/10/2019, 11:30 - 13:00, Vienna (2016)
-
+
OA14.04 - Five-Year Outcomes From the Randomized, Phase 3 Trials CheckMate 017/057: Nivolumab vs Docetaxel in Previously Treated NSCLC
12:00 - 12:10 | Presenter: Scott Gettinger
- Abstract
Loading...